Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Botswana Vaccine Maker Boosts Output to Secure Exports

Dec. 2 (Bloomberg) -- Botswana Vaccine Institute Ltd. opened a new 200 million pula ($30 million) testing laboratory to boost vaccinations and make sure the country’s beef is safe for export to Europe.

The facility will help to “secure livestock trade” to markets around the world, President Ian Khama said today at an opening ceremony in the capital, Gaborone. It will more than double annual antigen production, allowing for sales to other countries in Africa, he said.

State-owned BVI, in partnership with animal-treatments maker Merial BV, produces vaccines for diseases including Foot and Mouth, according to the state-owned company’s website. Botswana exports about 9,700 metric tons of beef to the European Union a year and also ships meat to Asia, the Middle East and South America, Khama said.

To contact the reporter on this story: Jerry Bungu in Gaborone at jbungu@bloomberg.net

To contact the editor responsible for this story: Antony Sguazzin at asguazzin@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.